The following is a summary of "Towards understanding cancer dormancy over strategic hitching up mechanisms to technologies," ...

Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 ...

This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...

Current asthma treatments don't work in all patients, and they don't provide long-term relief from potentially deadly asthma ...

Atrandi Biosciences, a life sciences company pioneering next-generation single-cell analysis technology, today announced a $25 million Series A funding round led by Lux Capital, with participation ...

The most scalable and high-resolution single cell solution available SEATTLE--BUSINESS WIRE--Parse Biosciences, the leader in high-throughput single ...

There are currently 82,000 incident cases of RCC annually in the United States (account for 3–5% of cancers), with 15,000 deaths annually in the United States. The overall 5-year mortality risk is ~30 ...

In the initial publication in 2021, the KETYNOTE-564 trial demonstrated that adjuvant pembrolizumab was associated with ...

Cells treated with ibrutinib and acalabrutinib each had a unique set of 13 m/z signals, which opens up the possibility of studying these metabolites as biomarkers of therapeutic response.

Early-career scholars recognized for pioneering work in statistics, physics, chemistry, astrophysics and computer science ...

A research team led by Professor Kevin Tsia, program director of the Biomedical Engineering Program under the Faculty of ...